机构:[1]Capital Med Univ, Beijing Childrens Hosp, Dept Haematol, Beijing, Peoples R China;医技科室血液中心首都医科大学附属北京儿童医院[2]Amer Yuva Biomed Inc, Beijing, Peoples R China;[3]Chinese PLA, Air Force Gen Hosp, Haematol, Beijing, Peoples R China
第一作者机构:[1]Capital Med Univ, Beijing Childrens Hosp, Dept Haematol, Beijing, Peoples R China;
推荐引用方式(GB/T 7714):
Zhao W.,Dong L.,Wang H.,et al.Chimeric Antigen Receptor 4SCAR-GD2/CD56-Modified T Cells in the Refractory and Recurrent Paediatric Solid Tumors[J].PEDIATRIC BLOOD & CANCER.2016,63:S38-S38.
APA:
Zhao, W.,Dong, L.,Wang, H.,Zheng, X.,Zhang, C....&Ma, X..(2016).Chimeric Antigen Receptor 4SCAR-GD2/CD56-Modified T Cells in the Refractory and Recurrent Paediatric Solid Tumors.PEDIATRIC BLOOD & CANCER,63,
MLA:
Zhao, W.,et al."Chimeric Antigen Receptor 4SCAR-GD2/CD56-Modified T Cells in the Refractory and Recurrent Paediatric Solid Tumors".PEDIATRIC BLOOD & CANCER 63.(2016):S38-S38